Kotsi ea Supartz bakeng sa Knee Osteoarthritis

Hvaluronate e amohelehang e sebelisetsoang ho ikoetlisa

Supartz, tharollo ea sodium hyaluronate, ke e 'ngoe ea li-hyaluronate tse sebelisoang ho viscosupplementation . Supartz e kenngoa ka ho toba ka lengole e le hore ho tsosolosoe thepa ea ho khomarela le ho hlahisa metsi a synovial fluid (ie, joint joint fluid). Sodium hyaluronate e sebelisoang Supartz e ntšoa likhopong tsa khōhō. Hyaluronate ea sodium ke polysaccharide e nang le li-unit tse sa phekoleheng tsa glucuronic acid le N-acetylglucosamine .

Tumelo ea Supartz le Supartz Fx

Supartz e ile ea amoheloa ke US FDA ka la 24 January, 2001 bakeng sa ho phekoloa ha masapo a masapo a mabeli ho bakuli ba hlōlehileng ho fumana phomolo e lekaneng ka phekolo ea meriana, ho kopanyelletsa ho ikoetlisa, phekolo ea meriana , meriana e bohloko , liphallelo tse tsamaeang le ho chesa . Ho sebelisoa manonyeletso a mang ho ntse ho phenyekolloa. Supartz e ne e sebelisoa Japane ho tloha ka 1987. E kenngoa hanngoe ka beke bakeng sa potoloho ea libeke tse 5. Bakuli ba bang ba ka 'na ba arabela hantle ka mor'a libeke tse tharo.

Ka la 12 October, 2015, Bioventus, moetsi oa Supartz, o phatlalalitse ho qalisoa ha Supartz Fx (10 mg ea hyaluronate ea sodium e qhibilihantsoeng le saline ea 'mele ea saline), e nang le letšoao le atolositsoeng la Supartz ea pele, e leng ho lumellang ho khutlisetsoa likokoana-hloko. Le hoja lengolo la polokeho le ne le atolosoa bakeng sa ente ea bobeli, katleho ea ho khutlela morao ha e e-s'o thehoe.

Litemoso le Tlhokomelo

Supartz ha ea lokela ho fanoa ho mokuli leha e le ofe ea nang le hypersensitivity tse tsebahalang ho lihlahisoa tsa sodium hyaluronate.

Tlhokomelo e lokela ho sebelisoa ha ho phekoloa bakuli ba tsejoang hore ba na le liprotheine tsa mavian, mahe kapa masiba. Bakuli ba nang le ts'oaetso kapa maloetse a letlalo sebakeng seo ho sona ho ka fanoang ka ente ha hoa lokela ho tšoaroa ka Supartz.

Ho sireletseha le katleho ea Supartz ha hoa thehoa ho basali ba nang le bakhachane, kapa ho basali ba nang le bokooa.

Tšebeliso ea eona ha e e-s'o ithutoe bana.

Liphello tse Tloaelehileng

Litla-morao tse tloaelehileng kapa liketsahalo tse bohloko tse amanang le Supartz li kenyelletsa:

Ho ruruha kapa bohloko, e leng nako e khutšoanyane, e ka etsahala ka motsoako o 'nileng oa kenngoa ke Supartz. Bakuli ba eletsoa ho qoba mesebetsi e boima kapa e boima ka lihora tse 48 ka mor'a hore e entsoe.

The Bottom Line

Ho hlahlojoa ha liteko tse 5 tse entsoeng hantle tse entsoeng hantle ha hoa ka ha senola phapang e kholo pakeng tsa Supartz le lihlopha tsa ho laola ka liketsahalo tse bohloko. Le hoja ts'ireletso ea Supartz le li-viscosupplements tse ling li tšehetsoe ke lithuto tsa bongaka, ho bile le lipuisano tse atlehileng. Mabapi le katleho, Phuputso ea Cochrane e fihlile qeto ea hore li-viscosupplementation li sebetsa hantle ho feta placebo, empa ho ne ho e-na le lithuto tse ling tse fokolang ho netefatsa hore liente li fana ka phomolo e kholo.

Lisebelisoa:

Supartz Fx. Ho hlalosa litaba. Bioventus. http://www.supartzfx.com/wp-content/uploads/2015/07/SUPARTZ_FX_Package_Insert.pdf

Bioventus e qalang Supartz Fx Hona joale ka Letšoao le Sireletsitsoeng la Tšireletso bakeng sa ho Pheta Likokoana-hloko tsa Kotsi ho Knee Osteoarthritis. La 12 October, 2015.
http://www.bioventusglobal.com/news/press-releases/bioventus-launches-supartz-fx%E2%84%A2-now-expanded-safety-label-repeat-injection-cycles

Hyaluronic acid (Supartz): tlhahlobo ea tšebeliso ea eona ho osteoarthritis ea lengole. MP MP. Lithethefatsi le ho tsofala. November 2010.
http://www.ncbi.nlm.nih.gov/pubmed/20964466